跳至主要内容
临床试验/ACTRN12611000118909
ACTRN12611000118909撤回2 期

Does adjunctive therapy with Minocycline improve pain and opioid effectiveness in complex lower limb trauma? - A prospective randomised controlled trial.

Dr David Lindholm0 个研究点目标入组 90 人开始时间: 2011年2月2日最近更新:
适应症

试验速览

阶段
2 期
状态
撤回
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 1. Aged between 18 and 65 years. 2. Admitted to The Alfred Hospital Emergency and Trauma Centre (ET&C) with complex lower limb trauma. These fractures would include Distal Femur types A2/3, B2/3, C2/3. Proximal Tibia Types A3, B3, C1/2/3. Tibial Shaft Types B2/3 C1/2/3. Distal Tibia Types A3, B3, C2/3.(20) Simple fractures not specified above with substantial full thickness tissue loss or compartment syndrome requiring fasciotomy or substantial crush mechanism will also be included.3. Low probability of requirement for prolonged ventilation (> 72 hours) 4. Patient is conscious and able to give informed consent OR patient’s person responsible is able to give informed consent on behalf of the patient. 5. Average of worst two pain scores(NRS)preceeding 24 h >6

排除标准

  • 1.Patients less than 18 years of age and greater than 65 years of age.
  • 2.Death is imminent (less than 24 hours).
  • 3.Patient not expected to survive 28 days because of an irreversible medical condition such as poorly controlled neoplasm or other end-stage disease.
  • 4.Pregnant or breast feeding.
  • 5.Patients with pre-burn psychiatric condition associated with psychotic or delusional symptomatology.
  • 6.Patients with drug and alcohol dependence.
  • 7.Patients with known hypersensitivity to minocycline or other tetracyclines.
  • 8.Patients with known hypersensitivity to ketamine.
  • 9.Patients with known hypersensitivity to pregabalin.
  • 10.History of active persistent pain syndrome at time of admission
  • 11.Opioid therapy in the two weeks preceding admission

研究者

发起方
Dr David Lindholm

相似试验